nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Doxorubicin—stomach cancer	0.576	1	CbGbCtD
Deferoxamine—XDH—Purine catabolism—NT5E—stomach cancer	0.0177	0.196	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—GMPR2—stomach cancer	0.0119	0.132	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—NT5E—stomach cancer	0.00681	0.0755	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—GMPR2—stomach cancer	0.00595	0.0661	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS3—stomach cancer	0.00465	0.0517	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PRDX5—stomach cancer	0.0046	0.051	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—NT5E—stomach cancer	0.00342	0.038	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—UMPS—stomach cancer	0.00313	0.0347	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—HMOX1—stomach cancer	0.00281	0.0312	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—TYMP—stomach cancer	0.00273	0.0303	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD2—stomach cancer	0.00263	0.0292	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—DPYD—stomach cancer	0.00217	0.0241	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALOX5—stomach cancer	0.002	0.0222	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—TYMS—stomach cancer	0.00124	0.0137	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD2—stomach cancer	0.00111	0.0124	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—MTHFR—stomach cancer	0.00098	0.0109	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—APOA1—stomach cancer	0.000902	0.01	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000716	0.00795	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALB—stomach cancer	0.000715	0.00793	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PTGS2—stomach cancer	0.000625	0.00694	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ACAD8—stomach cancer	0.000607	0.00674	CbGpPWpGaD
Deferoxamine—Visual impairment—Capecitabine—stomach cancer	0.000599	0.00179	CcSEcCtD
Deferoxamine—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000598	0.00179	CcSEcCtD
Deferoxamine—Paraesthesia—Irinotecan—stomach cancer	0.000592	0.00177	CcSEcCtD
Deferoxamine—Hypotension—Fluorouracil—stomach cancer	0.00059	0.00177	CcSEcCtD
Deferoxamine—Dyspnoea—Irinotecan—stomach cancer	0.000588	0.00176	CcSEcCtD
Deferoxamine—Blood creatinine increased—Epirubicin—stomach cancer	0.000586	0.00175	CcSEcCtD
Deferoxamine—Angiopathy—Docetaxel—stomach cancer	0.000582	0.00174	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL1B—stomach cancer	0.000582	0.00646	CbGpPWpGaD
Deferoxamine—Eye disorder—Capecitabine—stomach cancer	0.000581	0.00174	CcSEcCtD
Deferoxamine—Immune system disorder—Docetaxel—stomach cancer	0.00058	0.00173	CcSEcCtD
Deferoxamine—Tinnitus—Capecitabine—stomach cancer	0.000579	0.00173	CcSEcCtD
Deferoxamine—Mediastinal disorder—Docetaxel—stomach cancer	0.000578	0.00173	CcSEcCtD
Deferoxamine—Asthma—Methotrexate—stomach cancer	0.000578	0.00173	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000575	0.00172	CcSEcCtD
Deferoxamine—Arrhythmia—Docetaxel—stomach cancer	0.000573	0.00172	CcSEcCtD
Deferoxamine—Eosinophilia—Methotrexate—stomach cancer	0.000572	0.00171	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000569	0.0017	CcSEcCtD
Deferoxamine—Paraesthesia—Fluorouracil—stomach cancer	0.000567	0.0017	CcSEcCtD
Deferoxamine—Pain—Irinotecan—stomach cancer	0.000564	0.00169	CcSEcCtD
Deferoxamine—Angiopathy—Capecitabine—stomach cancer	0.000564	0.00169	CcSEcCtD
Deferoxamine—Dyspnoea—Fluorouracil—stomach cancer	0.000563	0.00169	CcSEcCtD
Deferoxamine—Immune system disorder—Capecitabine—stomach cancer	0.000561	0.00168	CcSEcCtD
Deferoxamine—Mediastinal disorder—Capecitabine—stomach cancer	0.00056	0.00168	CcSEcCtD
Deferoxamine—Erythema—Docetaxel—stomach cancer	0.000559	0.00167	CcSEcCtD
Deferoxamine—Arrhythmia—Capecitabine—stomach cancer	0.000555	0.00166	CcSEcCtD
Deferoxamine—Abdominal discomfort—Methotrexate—stomach cancer	0.000554	0.00166	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000545	0.00163	CcSEcCtD
Deferoxamine—Blood creatinine increased—Doxorubicin—stomach cancer	0.000542	0.00162	CcSEcCtD
Deferoxamine—XDH—Metabolism—GMPR2—stomach cancer	0.000541	0.006	CbGpPWpGaD
Deferoxamine—Erythema—Capecitabine—stomach cancer	0.000541	0.00162	CcSEcCtD
Deferoxamine—Asthma—Epirubicin—stomach cancer	0.000541	0.00162	CcSEcCtD
Deferoxamine—Dysuria—Methotrexate—stomach cancer	0.00054	0.00162	CcSEcCtD
Deferoxamine—Pain—Fluorouracil—stomach cancer	0.00054	0.00162	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000539	0.00161	CcSEcCtD
Deferoxamine—Muscle spasms—Docetaxel—stomach cancer	0.000537	0.00161	CcSEcCtD
Deferoxamine—Eosinophilia—Epirubicin—stomach cancer	0.000535	0.0016	CcSEcCtD
Deferoxamine—Abdominal pain—Irinotecan—stomach cancer	0.000521	0.00156	CcSEcCtD
Deferoxamine—Body temperature increased—Irinotecan—stomach cancer	0.000521	0.00156	CcSEcCtD
Deferoxamine—Muscle spasms—Capecitabine—stomach cancer	0.00052	0.00156	CcSEcCtD
Deferoxamine—Infestation—Methotrexate—stomach cancer	0.000515	0.00154	CcSEcCtD
Deferoxamine—Infestation NOS—Methotrexate—stomach cancer	0.000515	0.00154	CcSEcCtD
Deferoxamine—Vision blurred—Capecitabine—stomach cancer	0.00051	0.00153	CcSEcCtD
Deferoxamine—Renal failure—Methotrexate—stomach cancer	0.000506	0.00152	CcSEcCtD
Deferoxamine—Dysuria—Epirubicin—stomach cancer	0.000506	0.00151	CcSEcCtD
Deferoxamine—Urticaria—Fluorouracil—stomach cancer	0.000502	0.0015	CcSEcCtD
Deferoxamine—Asthma—Doxorubicin—stomach cancer	0.0005	0.0015	CcSEcCtD
Deferoxamine—Leukopenia—Docetaxel—stomach cancer	0.0005	0.0015	CcSEcCtD
Deferoxamine—Body temperature increased—Fluorouracil—stomach cancer	0.000499	0.00149	CcSEcCtD
Deferoxamine—Eosinophilia—Doxorubicin—stomach cancer	0.000495	0.00148	CcSEcCtD
Deferoxamine—XDH—Metabolism—SUCLG1—stomach cancer	0.000495	0.00549	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—IDH3B—stomach cancer	0.000495	0.00549	CbGpPWpGaD
Deferoxamine—Hypersensitivity—Irinotecan—stomach cancer	0.000486	0.00145	CcSEcCtD
Deferoxamine—Leukopenia—Capecitabine—stomach cancer	0.000484	0.00145	CcSEcCtD
Deferoxamine—Convulsion—Docetaxel—stomach cancer	0.000484	0.00145	CcSEcCtD
Deferoxamine—Infestation—Epirubicin—stomach cancer	0.000482	0.00144	CcSEcCtD
Deferoxamine—Infestation NOS—Epirubicin—stomach cancer	0.000482	0.00144	CcSEcCtD
Deferoxamine—Arthralgia—Docetaxel—stomach cancer	0.000476	0.00142	CcSEcCtD
Deferoxamine—Myalgia—Docetaxel—stomach cancer	0.000476	0.00142	CcSEcCtD
Deferoxamine—Renal failure—Epirubicin—stomach cancer	0.000474	0.00142	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000473	0.00141	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000472	0.00141	CcSEcCtD
Deferoxamine—Dysuria—Doxorubicin—stomach cancer	0.000468	0.0014	CcSEcCtD
Deferoxamine—Hypersensitivity—Fluorouracil—stomach cancer	0.000465	0.00139	CcSEcCtD
Deferoxamine—Arthralgia—Capecitabine—stomach cancer	0.00046	0.00138	CcSEcCtD
Deferoxamine—Myalgia—Capecitabine—stomach cancer	0.00046	0.00138	CcSEcCtD
Deferoxamine—XDH—Metabolism—NDUFV1—stomach cancer	0.00046	0.00511	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NDUFS1—stomach cancer	0.00046	0.00511	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000457	0.00137	CcSEcCtD
Deferoxamine—Urinary tract disorder—Methotrexate—stomach cancer	0.000457	0.00137	CcSEcCtD
Deferoxamine—Oedema—Docetaxel—stomach cancer	0.000456	0.00136	CcSEcCtD
Deferoxamine—Anaphylactic shock—Docetaxel—stomach cancer	0.000456	0.00136	CcSEcCtD
Deferoxamine—Urethral disorder—Methotrexate—stomach cancer	0.000453	0.00136	CcSEcCtD
Deferoxamine—Infection—Docetaxel—stomach cancer	0.000453	0.00136	CcSEcCtD
Deferoxamine—Diarrhoea—Irinotecan—stomach cancer	0.000451	0.00135	CcSEcCtD
Deferoxamine—Shock—Docetaxel—stomach cancer	0.000448	0.00134	CcSEcCtD
Deferoxamine—Nervous system disorder—Docetaxel—stomach cancer	0.000447	0.00134	CcSEcCtD
Deferoxamine—Pruritus—Fluorouracil—stomach cancer	0.000447	0.00134	CcSEcCtD
Deferoxamine—Thrombocytopenia—Docetaxel—stomach cancer	0.000446	0.00134	CcSEcCtD
Deferoxamine—Infestation—Doxorubicin—stomach cancer	0.000446	0.00134	CcSEcCtD
Deferoxamine—Infestation NOS—Doxorubicin—stomach cancer	0.000446	0.00134	CcSEcCtD
Deferoxamine—Visual impairment—Methotrexate—stomach cancer	0.000446	0.00133	CcSEcCtD
Deferoxamine—Tachycardia—Docetaxel—stomach cancer	0.000445	0.00133	CcSEcCtD
Deferoxamine—Skin disorder—Docetaxel—stomach cancer	0.000443	0.00133	CcSEcCtD
Deferoxamine—Oedema—Capecitabine—stomach cancer	0.000441	0.00132	CcSEcCtD
Deferoxamine—Bradycardia—Epirubicin—stomach cancer	0.000441	0.00132	CcSEcCtD
Deferoxamine—Renal failure—Doxorubicin—stomach cancer	0.000438	0.00131	CcSEcCtD
Deferoxamine—Infection—Capecitabine—stomach cancer	0.000438	0.00131	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000437	0.00131	CcSEcCtD
Deferoxamine—Dizziness—Irinotecan—stomach cancer	0.000436	0.00131	CcSEcCtD
Deferoxamine—Shock—Capecitabine—stomach cancer	0.000434	0.0013	CcSEcCtD
Deferoxamine—Nervous system disorder—Capecitabine—stomach cancer	0.000433	0.0013	CcSEcCtD
Deferoxamine—Eye disorder—Methotrexate—stomach cancer	0.000432	0.00129	CcSEcCtD
Deferoxamine—Diarrhoea—Fluorouracil—stomach cancer	0.000432	0.00129	CcSEcCtD
Deferoxamine—Thrombocytopenia—Capecitabine—stomach cancer	0.000432	0.00129	CcSEcCtD
Deferoxamine—Tinnitus—Methotrexate—stomach cancer	0.000431	0.00129	CcSEcCtD
Deferoxamine—Tachycardia—Capecitabine—stomach cancer	0.000431	0.00129	CcSEcCtD
Deferoxamine—Skin disorder—Capecitabine—stomach cancer	0.000429	0.00128	CcSEcCtD
Deferoxamine—Urinary tract disorder—Epirubicin—stomach cancer	0.000427	0.00128	CcSEcCtD
Deferoxamine—Hypotension—Docetaxel—stomach cancer	0.000426	0.00128	CcSEcCtD
Deferoxamine—Connective tissue disorder—Epirubicin—stomach cancer	0.000425	0.00127	CcSEcCtD
Deferoxamine—Urethral disorder—Epirubicin—stomach cancer	0.000424	0.00127	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—TNF—stomach cancer	0.000422	0.00468	CbGpPWpGaD
Deferoxamine—Angiopathy—Methotrexate—stomach cancer	0.00042	0.00126	CcSEcCtD
Deferoxamine—Vomiting—Irinotecan—stomach cancer	0.000419	0.00126	CcSEcCtD
Deferoxamine—Immune system disorder—Methotrexate—stomach cancer	0.000418	0.00125	CcSEcCtD
Deferoxamine—Dizziness—Fluorouracil—stomach cancer	0.000418	0.00125	CcSEcCtD
Deferoxamine—Visual impairment—Epirubicin—stomach cancer	0.000417	0.00125	CcSEcCtD
Deferoxamine—Mediastinal disorder—Methotrexate—stomach cancer	0.000417	0.00125	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000415	0.00124	CcSEcCtD
Deferoxamine—Headache—Irinotecan—stomach cancer	0.000413	0.00124	CcSEcCtD
Deferoxamine—Hypotension—Capecitabine—stomach cancer	0.000412	0.00123	CcSEcCtD
Deferoxamine—XDH—Metabolism—BLVRB—stomach cancer	0.00041	0.00455	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PGLS—stomach cancer	0.00041	0.00455	CbGpPWpGaD
Deferoxamine—Paraesthesia—Docetaxel—stomach cancer	0.000409	0.00123	CcSEcCtD
Deferoxamine—Bradycardia—Doxorubicin—stomach cancer	0.000408	0.00122	CcSEcCtD
Deferoxamine—Dyspnoea—Docetaxel—stomach cancer	0.000406	0.00122	CcSEcCtD
Deferoxamine—Eye disorder—Epirubicin—stomach cancer	0.000404	0.00121	CcSEcCtD
Deferoxamine—Tinnitus—Epirubicin—stomach cancer	0.000404	0.00121	CcSEcCtD
Deferoxamine—Erythema—Methotrexate—stomach cancer	0.000403	0.00121	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000402	0.0012	CcSEcCtD
Deferoxamine—Vomiting—Fluorouracil—stomach cancer	0.000402	0.0012	CcSEcCtD
Deferoxamine—Paraesthesia—Capecitabine—stomach cancer	0.000396	0.00119	CcSEcCtD
Deferoxamine—Headache—Fluorouracil—stomach cancer	0.000396	0.00118	CcSEcCtD
Deferoxamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000395	0.00118	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000394	0.00118	CcSEcCtD
Deferoxamine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000394	0.00118	CcSEcCtD
Deferoxamine—Dyspnoea—Capecitabine—stomach cancer	0.000393	0.00118	CcSEcCtD
Deferoxamine—Angiopathy—Epirubicin—stomach cancer	0.000393	0.00118	CcSEcCtD
Deferoxamine—Urethral disorder—Doxorubicin—stomach cancer	0.000393	0.00117	CcSEcCtD
Deferoxamine—Nausea—Irinotecan—stomach cancer	0.000392	0.00117	CcSEcCtD
Deferoxamine—XDH—Metabolism—PPAP2A—stomach cancer	0.000391	0.00434	CbGpPWpGaD
Deferoxamine—Immune system disorder—Epirubicin—stomach cancer	0.000391	0.00117	CcSEcCtD
Deferoxamine—Mediastinal disorder—Epirubicin—stomach cancer	0.00039	0.00117	CcSEcCtD
Deferoxamine—Pain—Docetaxel—stomach cancer	0.00039	0.00117	CcSEcCtD
Deferoxamine—Arrhythmia—Epirubicin—stomach cancer	0.000387	0.00116	CcSEcCtD
Deferoxamine—Visual impairment—Doxorubicin—stomach cancer	0.000386	0.00116	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000381	0.00114	CcSEcCtD
Deferoxamine—Vision blurred—Methotrexate—stomach cancer	0.000379	0.00114	CcSEcCtD
Deferoxamine—Pain—Capecitabine—stomach cancer	0.000377	0.00113	CcSEcCtD
Deferoxamine—Erythema—Epirubicin—stomach cancer	0.000377	0.00113	CcSEcCtD
Deferoxamine—Nausea—Fluorouracil—stomach cancer	0.000375	0.00112	CcSEcCtD
Deferoxamine—Eye disorder—Doxorubicin—stomach cancer	0.000374	0.00112	CcSEcCtD
Deferoxamine—Tinnitus—Doxorubicin—stomach cancer	0.000373	0.00112	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000373	0.00112	CcSEcCtD
Deferoxamine—Angiopathy—Doxorubicin—stomach cancer	0.000363	0.00109	CcSEcCtD
Deferoxamine—Muscle spasms—Epirubicin—stomach cancer	0.000362	0.00108	CcSEcCtD
Deferoxamine—Immune system disorder—Doxorubicin—stomach cancer	0.000362	0.00108	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000361	0.00108	CcSEcCtD
Deferoxamine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000361	0.00108	CcSEcCtD
Deferoxamine—Abdominal pain—Docetaxel—stomach cancer	0.00036	0.00108	CcSEcCtD
Deferoxamine—Body temperature increased—Docetaxel—stomach cancer	0.00036	0.00108	CcSEcCtD
Deferoxamine—Leukopenia—Methotrexate—stomach cancer	0.00036	0.00108	CcSEcCtD
Deferoxamine—Arrhythmia—Doxorubicin—stomach cancer	0.000358	0.00107	CcSEcCtD
Deferoxamine—Vision blurred—Epirubicin—stomach cancer	0.000355	0.00106	CcSEcCtD
Deferoxamine—Urticaria—Capecitabine—stomach cancer	0.000351	0.00105	CcSEcCtD
Deferoxamine—Abdominal pain—Capecitabine—stomach cancer	0.000349	0.00104	CcSEcCtD
Deferoxamine—Body temperature increased—Capecitabine—stomach cancer	0.000349	0.00104	CcSEcCtD
Deferoxamine—Convulsion—Methotrexate—stomach cancer	0.000349	0.00104	CcSEcCtD
Deferoxamine—Erythema—Doxorubicin—stomach cancer	0.000349	0.00104	CcSEcCtD
Deferoxamine—XDH—Metabolism—NDUFA2—stomach cancer	0.000349	0.00387	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CA1—stomach cancer	0.000349	0.00387	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CKB—stomach cancer	0.000349	0.00387	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—FBP1—stomach cancer	0.000349	0.00387	CbGpPWpGaD
Deferoxamine—Arthralgia—Methotrexate—stomach cancer	0.000343	0.00103	CcSEcCtD
Deferoxamine—Myalgia—Methotrexate—stomach cancer	0.000343	0.00103	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL6—stomach cancer	0.000341	0.00378	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00034	0.00102	CcSEcCtD
Deferoxamine—Leukopenia—Epirubicin—stomach cancer	0.000337	0.00101	CcSEcCtD
Deferoxamine—Hypersensitivity—Docetaxel—stomach cancer	0.000336	0.00101	CcSEcCtD
Deferoxamine—Muscle spasms—Doxorubicin—stomach cancer	0.000335	0.001	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methotrexate—stomach cancer	0.000329	0.000983	CcSEcCtD
Deferoxamine—Vision blurred—Doxorubicin—stomach cancer	0.000329	0.000983	CcSEcCtD
Deferoxamine—XDH—Metabolism—PLIN2—stomach cancer	0.000328	0.00364	CbGpPWpGaD
Deferoxamine—Convulsion—Epirubicin—stomach cancer	0.000326	0.000977	CcSEcCtD
Deferoxamine—Infection—Methotrexate—stomach cancer	0.000326	0.000977	CcSEcCtD
Deferoxamine—Hypersensitivity—Capecitabine—stomach cancer	0.000325	0.000973	CcSEcCtD
Deferoxamine—Pruritus—Docetaxel—stomach cancer	0.000323	0.000965	CcSEcCtD
Deferoxamine—Nervous system disorder—Methotrexate—stomach cancer	0.000322	0.000964	CcSEcCtD
Deferoxamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000322	0.000963	CcSEcCtD
Deferoxamine—Arthralgia—Epirubicin—stomach cancer	0.000321	0.00096	CcSEcCtD
Deferoxamine—Myalgia—Epirubicin—stomach cancer	0.000321	0.00096	CcSEcCtD
Deferoxamine—Skin disorder—Methotrexate—stomach cancer	0.000319	0.000955	CcSEcCtD
Deferoxamine—XDH—Metabolism—CA2—stomach cancer	0.000319	0.00354	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000319	0.000953	CcSEcCtD
Deferoxamine—Pruritus—Capecitabine—stomach cancer	0.000312	0.000935	CcSEcCtD
Deferoxamine—Leukopenia—Doxorubicin—stomach cancer	0.000312	0.000934	CcSEcCtD
Deferoxamine—Diarrhoea—Docetaxel—stomach cancer	0.000312	0.000934	CcSEcCtD
Deferoxamine—XDH—Metabolism—NT5E—stomach cancer	0.000311	0.00345	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PGAM1—stomach cancer	0.000311	0.00345	CbGpPWpGaD
Deferoxamine—Oedema—Epirubicin—stomach cancer	0.000307	0.00092	CcSEcCtD
Deferoxamine—Anaphylactic shock—Epirubicin—stomach cancer	0.000307	0.00092	CcSEcCtD
Deferoxamine—Hypotension—Methotrexate—stomach cancer	0.000307	0.000919	CcSEcCtD
Deferoxamine—Infection—Epirubicin—stomach cancer	0.000305	0.000914	CcSEcCtD
Deferoxamine—Shock—Epirubicin—stomach cancer	0.000303	0.000905	CcSEcCtD
Deferoxamine—Convulsion—Doxorubicin—stomach cancer	0.000302	0.000904	CcSEcCtD
Deferoxamine—Diarrhoea—Capecitabine—stomach cancer	0.000302	0.000904	CcSEcCtD
Deferoxamine—Nervous system disorder—Epirubicin—stomach cancer	0.000302	0.000903	CcSEcCtD
Deferoxamine—Dizziness—Docetaxel—stomach cancer	0.000301	0.000902	CcSEcCtD
Deferoxamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000301	0.000901	CcSEcCtD
Deferoxamine—Tachycardia—Epirubicin—stomach cancer	0.0003	0.000898	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000299	0.000896	CcSEcCtD
Deferoxamine—Skin disorder—Epirubicin—stomach cancer	0.000299	0.000894	CcSEcCtD
Deferoxamine—Myalgia—Doxorubicin—stomach cancer	0.000297	0.000888	CcSEcCtD
Deferoxamine—Arthralgia—Doxorubicin—stomach cancer	0.000297	0.000888	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDH7A1—stomach cancer	0.000296	0.00329	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLCE1—stomach cancer	0.000296	0.00329	CbGpPWpGaD
Deferoxamine—Paraesthesia—Methotrexate—stomach cancer	0.000295	0.000883	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000295	0.000882	CcSEcCtD
Deferoxamine—Dyspnoea—Methotrexate—stomach cancer	0.000293	0.000877	CcSEcCtD
Deferoxamine—Dizziness—Capecitabine—stomach cancer	0.000292	0.000874	CcSEcCtD
Deferoxamine—Vomiting—Docetaxel—stomach cancer	0.00029	0.000868	CcSEcCtD
Deferoxamine—Hypotension—Epirubicin—stomach cancer	0.000287	0.00086	CcSEcCtD
Deferoxamine—Headache—Docetaxel—stomach cancer	0.000286	0.000855	CcSEcCtD
Deferoxamine—Oedema—Doxorubicin—stomach cancer	0.000284	0.000852	CcSEcCtD
Deferoxamine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000284	0.000852	CcSEcCtD
Deferoxamine—XDH—Metabolism—UMPS—stomach cancer	0.000284	0.00315	CbGpPWpGaD
Deferoxamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000284	0.000849	CcSEcCtD
Deferoxamine—Infection—Doxorubicin—stomach cancer	0.000283	0.000846	CcSEcCtD
Deferoxamine—Pain—Methotrexate—stomach cancer	0.000281	0.000841	CcSEcCtD
Deferoxamine—Vomiting—Capecitabine—stomach cancer	0.000281	0.00084	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00028	0.000839	CcSEcCtD
Deferoxamine—Shock—Doxorubicin—stomach cancer	0.00028	0.000838	CcSEcCtD
Deferoxamine—Nervous system disorder—Doxorubicin—stomach cancer	0.000279	0.000835	CcSEcCtD
Deferoxamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000279	0.000834	CcSEcCtD
Deferoxamine—Tachycardia—Doxorubicin—stomach cancer	0.000278	0.000831	CcSEcCtD
Deferoxamine—Headache—Capecitabine—stomach cancer	0.000276	0.000828	CcSEcCtD
Deferoxamine—Skin disorder—Doxorubicin—stomach cancer	0.000276	0.000827	CcSEcCtD
Deferoxamine—Paraesthesia—Epirubicin—stomach cancer	0.000276	0.000826	CcSEcCtD
Deferoxamine—Dyspnoea—Epirubicin—stomach cancer	0.000274	0.000821	CcSEcCtD
Deferoxamine—Nausea—Docetaxel—stomach cancer	0.000271	0.000811	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000269	0.000804	CcSEcCtD
Deferoxamine—Hypotension—Doxorubicin—stomach cancer	0.000266	0.000796	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000265	0.000795	CcSEcCtD
Deferoxamine—XDH—Metabolism—PDHA1—stomach cancer	0.000264	0.00293	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ECHS1—stomach cancer	0.000264	0.00293	CbGpPWpGaD
Deferoxamine—Pain—Epirubicin—stomach cancer	0.000263	0.000787	CcSEcCtD
Deferoxamine—Nausea—Capecitabine—stomach cancer	0.000262	0.000785	CcSEcCtD
Deferoxamine—Urticaria—Methotrexate—stomach cancer	0.000261	0.000781	CcSEcCtD
Deferoxamine—Abdominal pain—Methotrexate—stomach cancer	0.00026	0.000777	CcSEcCtD
Deferoxamine—Body temperature increased—Methotrexate—stomach cancer	0.00026	0.000777	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000259	0.000776	CcSEcCtD
Deferoxamine—Paraesthesia—Doxorubicin—stomach cancer	0.000255	0.000765	CcSEcCtD
Deferoxamine—Dyspnoea—Doxorubicin—stomach cancer	0.000254	0.000759	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000251	0.000753	CcSEcCtD
Deferoxamine—XDH—Metabolism—FADS1—stomach cancer	0.000248	0.00276	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—TYMP—stomach cancer	0.000248	0.00276	CbGpPWpGaD
Deferoxamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000246	0.000735	CcSEcCtD
Deferoxamine—Urticaria—Epirubicin—stomach cancer	0.000244	0.000731	CcSEcCtD
Deferoxamine—Pain—Doxorubicin—stomach cancer	0.000243	0.000728	CcSEcCtD
Deferoxamine—Abdominal pain—Epirubicin—stomach cancer	0.000243	0.000728	CcSEcCtD
Deferoxamine—Body temperature increased—Epirubicin—stomach cancer	0.000243	0.000728	CcSEcCtD
Deferoxamine—Hypersensitivity—Methotrexate—stomach cancer	0.000242	0.000725	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000233	0.000696	CcSEcCtD
Deferoxamine—XDH—Metabolism—SREBF2—stomach cancer	0.000233	0.00258	CbGpPWpGaD
Deferoxamine—Pruritus—Methotrexate—stomach cancer	0.000232	0.000696	CcSEcCtD
Deferoxamine—XDH—Metabolism—RORA—stomach cancer	0.00023	0.00255	CbGpPWpGaD
Deferoxamine—Hypersensitivity—Epirubicin—stomach cancer	0.000227	0.000678	CcSEcCtD
Deferoxamine—Urticaria—Doxorubicin—stomach cancer	0.000226	0.000677	CcSEcCtD
Deferoxamine—Abdominal pain—Doxorubicin—stomach cancer	0.000225	0.000673	CcSEcCtD
Deferoxamine—Body temperature increased—Doxorubicin—stomach cancer	0.000225	0.000673	CcSEcCtD
Deferoxamine—Diarrhoea—Methotrexate—stomach cancer	0.000225	0.000673	CcSEcCtD
Deferoxamine—Pruritus—Epirubicin—stomach cancer	0.000218	0.000651	CcSEcCtD
Deferoxamine—Dizziness—Methotrexate—stomach cancer	0.000217	0.00065	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDOB—stomach cancer	0.000215	0.00239	CbGpPWpGaD
Deferoxamine—Diarrhoea—Epirubicin—stomach cancer	0.00021	0.00063	CcSEcCtD
Deferoxamine—Hypersensitivity—Doxorubicin—stomach cancer	0.00021	0.000627	CcSEcCtD
Deferoxamine—Vomiting—Methotrexate—stomach cancer	0.000209	0.000625	CcSEcCtD
Deferoxamine—Headache—Methotrexate—stomach cancer	0.000206	0.000616	CcSEcCtD
Deferoxamine—Dizziness—Epirubicin—stomach cancer	0.000203	0.000609	CcSEcCtD
Deferoxamine—Pruritus—Doxorubicin—stomach cancer	0.000201	0.000602	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALOX5—stomach cancer	0.0002	0.00222	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—DPYD—stomach cancer	0.000197	0.00219	CbGpPWpGaD
Deferoxamine—Vomiting—Epirubicin—stomach cancer	0.000195	0.000585	CcSEcCtD
Deferoxamine—Nausea—Methotrexate—stomach cancer	0.000195	0.000584	CcSEcCtD
Deferoxamine—Diarrhoea—Doxorubicin—stomach cancer	0.000195	0.000583	CcSEcCtD
Deferoxamine—Headache—Epirubicin—stomach cancer	0.000193	0.000577	CcSEcCtD
Deferoxamine—Dizziness—Doxorubicin—stomach cancer	0.000188	0.000563	CcSEcCtD
Deferoxamine—Nausea—Epirubicin—stomach cancer	0.000183	0.000547	CcSEcCtD
Deferoxamine—Vomiting—Doxorubicin—stomach cancer	0.000181	0.000541	CcSEcCtD
Deferoxamine—Headache—Doxorubicin—stomach cancer	0.000178	0.000533	CcSEcCtD
Deferoxamine—XDH—Metabolism—GSTT1—stomach cancer	0.000174	0.00193	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP2A6—stomach cancer	0.000172	0.00191	CbGpPWpGaD
Deferoxamine—Nausea—Doxorubicin—stomach cancer	0.000169	0.000506	CcSEcCtD
Deferoxamine—XDH—Metabolism—AKR1C3—stomach cancer	0.000167	0.00186	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ENO1—stomach cancer	0.000163	0.00181	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CD44—stomach cancer	0.000145	0.00161	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPP2R1A—stomach cancer	0.000123	0.00137	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTP1—stomach cancer	0.000121	0.00134	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMOX1—stomach cancer	0.000119	0.00132	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—TYMS—stomach cancer	0.000112	0.00125	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTM1—stomach cancer	0.000111	0.00123	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ERCC2—stomach cancer	0.000104	0.00116	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MTHFR—stomach cancer	9.8e-05	0.00109	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CAV1—stomach cancer	9.04e-05	0.001	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA1—stomach cancer	9.02e-05	0.001	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARG—stomach cancer	7.95e-05	0.000882	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALB—stomach cancer	7.15e-05	0.000793	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NOS3—stomach cancer	6.84e-05	0.000759	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGS2—stomach cancer	6.25e-05	0.000694	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CA—stomach cancer	3.85e-05	0.000427	CbGpPWpGaD
